AbbVie (ABBV): A Resilient Dividend Pick Despite Patent Challenges
AbbVie's Humira Faces Challenges, but New Treatments and Dividends Shine
AbbVie, a seasoned player in the pharmaceutical...
Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that...
Stocks ticked lower as Treasury yield rates rose after the release of the Labor Department’s employment report for June revealed unexpected strength in the...